David S Halsted, MD | |
2115 N Kansas Ave, #201, Hastings, NE 68901-2644 | |
(402) 462-5109 | |
(402) 462-6368 |
Full Name | David S Halsted |
---|---|
Gender | Male |
Speciality | Urology |
Location | 2115 N Kansas Ave, Hastings, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578557070 | NPI | - | NPPES |
47056069100 | Medicaid | NE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 20214 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
David S Halsted, MD Po Box 249, 2115 N Kansas Ave #201, Hastings, NE 68902-0249 Ph: (402) 462-5109 | David S Halsted, MD 2115 N Kansas Ave, #201, Hastings, NE 68901-2644 Ph: (402) 462-5109 |
News Archive
In a new article from the National Institutes of Health (NIH), Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), and Harold Varmus, M.D., director of the National Cancer Institute (NCI), join Gary Nabel, M.D., Ph.D., director of NIAID's Vaccine Research Center, and Jeffrey Cohen, M.D., chief of NIAID's Laboratory of Infectious Diseases, in summarizing a recent meeting of experts who gathered to map directions toward an EBV vaccine.
A UCSF-led study examining the impact of statins on the progression of multiple sclerosis found a lower incidence of new brain lesions in patients taking the cholesterol-lowering drug in the early stages of the disease as compared to a placebo.
Young adults who survived childhood cancer are more likely than their peers to be frail, according to a St. Jude Children's Research Hospital study, which reported the condition is more common among female survivors than women decades older. The research appears in the November 18 online edition of the Journal of Clinical Oncology.
ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced initial safety and preliminary anti-tumor activity from the FORWARD II expansion cohort assessing mirvetuximab soravtansine in combination with Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab).
In political developments, a new poll shows a significant divide among Catholics but little support among general voters for the church's complaints about the Obama administration rule. Also, in Minnesota, a new candidate opens his campaign for Congress and criticizes the state's handling of Medicaid funds.
› Verified 3 days ago
Raymond W Conant, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2115 N Kansas Ave, #201, Hastings, NE 68901 Phone: 402-462-5109 Fax: 402-462-6368 | |
Dr. Christopher Kevin Kubat, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 301 W 7th St, Hastings, NE 68901 Phone: 402-984-3955 |